University of Chicago Medicine researchers developed a new risk score, US-CRS, for predicting death without heart transplant, aiming to improve upon the current 6-status system.

A research team led by experts at the University of Chicago Medicine has developed a new risk score designed to predict the likelihood that a patient will die without a heart transplant. This innovation aims to address the limitations of the current therapy-based 6-status system, offering a more precise and fair approach to prioritizing candidates based on medical urgency. The research team published their findings in JAMA in February 2024. The new risk score, called the U.S. Candidate Risk Score (US-CRS), was found to be more accurate at predicting death without transplant within 6 weeks in a test dataset of U.S. adult heart transplant candidates listed from 2019 to 2022.

February 13, 2024
6 Articles